Filters
Survivors of complicated urinary tract infections (cUTI) are commonly readmitted for recurrent UTI, usually related to other medical conditions that require urinary interventions, a recent study has found.
New drug applications approved by US FDA as of 16-31 March 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
In patients with metastatic papillary renal cell carcinoma (PRCC), cabozantinib led to greater progression-free survival (PFS) and overall response rate (ORR) than sunitinib, results of the phase II SWOG 1500 study showed.
Focal therapy of significant localized prostate cancer associated with a magnetic resonance imaging (MRI) lesion using bipolar radiofrequency appears effective in ablating cancer, with low rates of genitourinary and rectal side effects, according to a study.
An association exists between magnetic resonance imaging (MRI) findings of localized prostate cancer and clinically relevant long-term oncologic outcomes, a study has found.
Treatment with 100-mg sildenafil appears to be the best strategy to improve erectile function recovery rates after radical prostatectomy, suggests a study. However, the on-demand dose of phosphodiesterase-5 (PDE5) inhibitors does not appear to be any better than placebo and must therefore not be considered as a penile rehabilitation strategy.
Prostate cancer seems to have no long-term adverse effects on survivors’ sexual, genitourinary, and general quality of life, a recent study has found.
Consumption of a newly developed whole tomato‑based food supplement* (WTFS) led to improvements in lower urinary tract symptoms** (LUTS) and quality of life (QoL) in men with benign prostatic hyperplasia (BPH), a phase II Italian study has shown.
Around-the-clock administration of intravenous acetaminophen lowers postoperative pain and the need for emergency analgesia after robot-assisted radical prostatectomy, a recent study has shown.
In children, dehiscence, severe recurrent ventral curvature, and urethral strictures all aggravate the risk of reoperation after primary hypospadias repair, a recent study.
